Commentary: Goals of surgical therapy in tricuspid valve endocarditis

The incidence of infective endocarditis is on the rise, and this condition remains associated with high rates of morbidity and mortality, despite advances in diagnosis and treatment.1 The worsening epidemic of intravenous drug abuse (IVDA) and the increasing rates of indwelling chronic venous lines and implantable cardiac devices have resulted in a recent surge of cases of tricuspid valve endocarditis. Right-sided infective endocarditis occurs far less frequently (5%-10% of total infective endocarditis cases) than does left-sided infective endocarditis, with most cases primarily affecting the tricuspid valve.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Commentary Source Type: research